Since its beginnings, the NHS has had a close relationship with the pharmaceutical industry. While not an official public-private partnership (PPP) there has been, in effect, an implicit PPP for pharmaceutical research and provision. This partnership has been an undoubted economic success. However, the interests of users of the health ...
This new policy paper, which follows up an interim report published in 2002, aims to take a fresh look at the issues facing planners, policy makers and managers responsible for maintaining and developing the health care workforces in London, and to tease out some of the opportunities, as well as ...
This publication lays out the questions the government must answer if it wants to place patient choice at the heart of a taxpayer-funded health care system, including how extra costs will be met, whether patients are willing and able to exercise choice in their own best interests, and what kinds ...
A wide range of public services - including higher education, housing associations and public service broadcasting - are now either funded, delivered, or regulated through agencies working at 'arm's length' from government. Is it time to consider a similar model for the modern NHS? Does the health service need to ...
As the government seeks to accelerate change in the NHS and make services more responsive to public demands, the argument for market discipline versus planned provision is being hotly debated: can a highly centralised system sit comfortably alongside a market-led approach?; can market forces provide an effective response to the ...